undamentalytics Newsletter
Sign in

Strata Critical Medical, Inc. income statement

In fiscal 2025, Strata Critical Medical, Inc. reported revenue of $197m, up 34.3% on the year before, operating income of −$22.4m (a -11.3% margin) and net income of $41.3m, or $0.50 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Sept 20192020Sept 20202021Sept 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue312351146225147197281
Cost of revenue262140124183117156220
Gross profit52112242304161
Research and development112653——
Selling, general and administrative—————516164
Selling and marketing533810———
General and administrative109306395———
Operating income−12−10−24−54−68−23−22−19
Net interest income100387——
Income before tax−11−10−44−28−58−16−20−21
Income tax00−4−1−1000
Net income−11−10−40−27−56−2741−25
Diluted EPS−$0.43−$0.40−$0.93−$0.38−$0.76−$0.35$0.50−$0.28
Diluted shares (average)25m25m43m71m74m77m82m87m
EBITDA−11−10−23−48−61−17−14−9

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DCGO vs SRTASRTA vs VMDDLHC vs SRTA

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Strata Critical Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Strata Critical Medical, Inc.